These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30892982)

  • 1. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
    J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
    [No Abstract]   [Full Text] [Related]  

  • 2. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019.
    Girardi M; Carlson K; Huang X; Corman SL; Edmundson P; Schmier J; Kale HP; Raina R; Foss F
    J Dermatolog Treat; 2024 Dec; 35(1):2360568. PubMed ID: 38852942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S; Abhyankar S; Herd TJ; Aires D
    J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
    Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
    Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
    Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
    Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
    Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
    Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD209
    Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients.
    Bladon J; Taylor PC
    Br J Haematol; 1999 Dec; 107(4):707-11. PubMed ID: 10606873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T
    Peacock A; Dehle F; Mesa Zapata OA; Prince HM; Gennari F; Taylor C
    Value Health; 2022 Jun; 25(6):965-974. PubMed ID: 35667784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
    Gollnick HP; Owsianowski M; Ramaker J; Chun SC; Orfanos CE
    Recent Results Cancer Res; 1995; 139():409-15. PubMed ID: 7597308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
    Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
    Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B; Behrens W; Hölzle E; Plewig G
    Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous T cell lymphoma: current status and future directions.
    Apisarnthanarax N; Talpur R; Duvic M
    Am J Clin Dermatol; 2002; 3(3):193-215. PubMed ID: 11978140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E; Vonderheid EC; Geskin L
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.